ConductScience.org, home

Paper · 10691919

Mechanisms of the in vitro fungicidal effects of human neutrophils against Penicillium marneffei induced by granulocyte-macrophage colony-stimulating factor (GM-CSF).

Kudeken N and 2 others. Clin Exp Immunol, 2000. Cited by 26 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Mechanisms of the in vitro fungicidal effects of human neutrophils against Penicillium marneffei induced by granulocyte-macrophage colony-stimulating factor (GM-CSF). Papers, record 10691919. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/10691919

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Mechanisms of the in vitro fungicidal effects of human neutrophils against Penicillium marneffei induced by granulocyte-macrophage colony-stimulating factor (GM-CSF).
PubMed
Journal
Clin Exp Immunol
PubMed
Year
2000
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
26
iCite
Relative citation ratio, by iCite
0.75
iCite
Revised in PubMed
2019-05-13
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kudeken NN
2Kawakami KK
3Saito AA

Source PubMed

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Granulocyte-Macrophage Colony-Stimulating FactorMajor topic
Neutrophil ActivationMajor topic
NeutrophilsMajor topic
PenicilliumMajor topic
Antifungal Agents
Cells, Cultured
Humans

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References35

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
17,912,350Disseminated Penicillium marneffei infection in southeast Asia.Lancet1994https://conductscience.org/library/papers/7912350PubMed
28,307,142In vitro susceptibility of mycelial and yeast forms of Penicillium marneffei to amphotericin B, fluconazole, 5-fluorocytosine and itraconazole.Eur J Epidemiol1993https://conductscience.org/library/papers/8307142PubMed
38,643,813Fungal infections: a growing threat.Public Health Rep1996https://conductscience.org/library/papers/8643813PubMed
48,641,399Antibiotic proteins of polymorphonuclear leukocytes.Eur J Haematol1996https://conductscience.org/library/papers/8641399PubMed
58,702,012Preventing opportunistic infections in human immunodeficiency virus-infected persons: implications for the developing world.Am J Trop Med Hyg1996https://conductscience.org/library/papers/8702012PubMed
68,971,625Cell-mediated immunity in host resistance against infection caused by Penicillium marneffei.J Med Vet Mycol1996https://conductscience.org/library/papers/8971625PubMed
78,975,924Development of an in vitro macrophage system to assess Penicillium marneffei growth and susceptibility to nitric oxide.Infect Immun1997https://conductscience.org/library/papers/8975924PubMed
89,038,306Porcine polymorphonuclear leukocytes generate extracellular microbicidal activity by elastase-mediated activation of secreted proprotegrins.Infect Immun1997https://conductscience.org/library/papers/9038306PubMed
99,067,519CD4+ T cell-mediated fatal hyperinflammatory reactions in mice infected with Penicillium marneffei.Clin Exp Immunol1997https://conductscience.org/library/papers/9067519PubMed
109,649,193Different susceptibilities of yeasts and conidia of Penicillium marneffei to nitric oxide (NO)-mediated fungicidal activity of murine macrophages.Clin Exp Immunol1998https://conductscience.org/library/papers/9649193PubMed

Cited by10

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 26 citations.

PMIDTitleJournalYearIn PapersSource
41,257,635
Clinical spectrum of Talaromyces marneffei infections in HIV-negative patients: an 18-case series including a rare presentation with gastrointestinal onset, adrenal mass, and hemophagocytic lymphohistiocytosis.
BMC Infect Dis2025https://conductscience.org/library/papers/41257635PubMed
37,055,706Clinical Characteristics, Course, and Long-Term Outcomes in Patients with Talaromyces marneffei Infection: A 10-Year Retrospective Cohort Study.Infect Dis Ther2023https://conductscience.org/library/papers/37055706PubMed
35,205,954Talaromyces marneffei Infection: Virulence, Intracellular Lifestyle and Host Defense Mechanisms.J Fungi (Basel)2022https://conductscience.org/library/papers/35205954PubMed
34,512,824Clinical characteristics and risk factors of Talaromyces marneffei infection in human immunodeficiency virus-negative patients: A retrospective observational study.World J Emerg Med2021https://conductscience.org/library/papers/34512824PubMed
33,499,053The Host Immune Response to Scedosporium/Lomentospora.J Fungi (Basel)2021https://conductscience.org/library/papers/33499053PubMed
30,429,9757-Deacetyl-10-alkylthiocolchicine derivatives - new compounds with potent anticancer and fungicidal activity.Medchemcomm2018https://conductscience.org/library/papers/30429975PubMed
28,884,011Adaptation to macrophage killing by Talaromyces marneffei.Future Sci OA2017https://conductscience.org/library/papers/28884011PubMed
27,224,737Talaromyces marneffei laccase modifies THP-1 macrophage responses.Virulence2016https://conductscience.org/library/papers/27224737PubMed
16,418,525Penicillium marneffei infection and recent advances in the epidemiology and molecular biology aspects.Clin Microbiol Rev2006https://conductscience.org/library/papers/16418525PubMed
11,349,055
Lactoferrin peptide increases the survival of Candida albicans-inoculated mice by upregulating neutrophil and macrophage functions, especially in combination with amphotericin B and granulocyte-macrophage colony-stimulating factor.
Infect Immun2001https://conductscience.org/library/papers/11349055PubMed

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CSF21,437PubTator's text mininghttps://conductscience.org/library/genes/1437NCBI Gene
SOD16,647PubTator's text mininghttps://conductscience.org/library/genes/6647NCBI Gene

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/10691919

GET https://conductscience.org/api/papers/v1/10691919/references?page=2